| Type : |
Journal |
| Internett-koblingen : |
https://doi.org/10.1016/j.ijpharm.2005.08.007 |
|
| Forskerteamet : |
Ann Arbor - Pfizer Global Research & Development |
| Forfattere : |
Freed A.L, Silbering S.B, Kolodsick K.J, Rossi D, Mahjour M, Kingsmill C.A. |
| Tittel : |
The development and stability assessment of extemporaneous pediatric formulations of Accupril. |
| Nummer : |
Int J Pharm 304; 1-2: 135-144. 2005 |
|
| Nivå of Evidence : |
|
| Fysisk stabilitet : |
|
| Kjemisk stabilitet : |
|
| Andre metoder : |
|
| Kommentarer : |
|
Lister
 Quinapril
|
 |
 |
 |
 |
200 mg
Accupril® |
| Kphos® |
30 ml |
| Bicitra® |
30 ml |
| Orasweet® |
>> 200 ml |
|
5°C |
 |
| 42 |
 |
|
|
|
|
|
200 mg
Accupril® |
| Kphos® |
30 ml |
| Bicitra® |
30 ml |
| Orasweet SF ® |
>> 200 ml |
|
5°C |
|
| 42 |
|
|
|
|
|
|
200 mg
Accupril® |
| Kphos® |
30 ml |
| Bicitra® |
30 ml |
| Sukkersirup |
>> 200 ml |
|
5°C |
|
| 42 |
|
|
|
|
|
